The prognostic value of cytotoxic T-lymphocyte antigen 4 in cancers: a systematic review and meta-analysis

CTLA-4 in mesothelioma patients: tissue expression, body fluid levels and possible relevance as a prognostic factor

(2016) Silvio Roncella et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Cytotoxic T lymphocyte antigen 4 expression in human breast cancer: implications for prognosis

(2015) Haiming Yu et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Tumor-infiltrating lymphocytes, forkhead box P3, programmed death ligand-1, and cytotoxic T lymphocyte–associated antigen-4 expressions before and after neoadjuvant chemoradiation in rectal cancer

(2015) Feifei Teng et al.   Translational Research

Cytotoxic T-Lymphocyte Antigen-4 Single Nucleotide Polymorphisms Are Not Associated with Outcomes after Unrelated Donor Transplantation: A Center for International Blood and Marrow Transplant Research Analysis

(2014) Salyka Sengsayadeth et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Immune Checkpoint Inhibitors in NSCLC

(2014) Douglas B. Johnson et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

Targeting the alternatively spliced soluble isoform of CTLA-4: prospects for immunotherapy?

(2014) Frank J Ward et al.   Immunotherapy

Four-year survival rates for patients with metastatic melanoma who received ipilimumab in phase II clinical trials

(2013) J. D. Wolchok et al.   ANNALS OF ONCOLOGY

Phase III Randomized Clinical Trial Comparing Tremelimumab With Standard-of-Care Chemotherapy in Patients With Advanced Melanoma

(2013) Antoni Ribas et al.   JOURNAL OF CLINICAL ONCOLOGY

Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4

(2013) Rikke B. Holmgaard et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Role of CTLA4 in the Proliferation and Survival of Chronic Lymphocytic Leukemia

(2013) Amit K. Mittal et al.   PLoS One

Evaluation of CTLA-4 expression and relevance as a novel prognostic factor in patients with non-small cell lung cancer

(2012) Sandra Salvi et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Genetic variations in T-cell activation and effector pathways modulate alloimmune responses after allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies

(2012) H. Xiao et al.   HAEMATOLOGICA

Intracellular CTLA4 and Regulatory T Cells in Patients with Laryngeal Squamous Cell Carcinoma

(2012) Nasrollah Erfani et al.   IMMUNOLOGICAL INVESTIGATIONS

Differing Patterns of Circulating Regulatory T Cells and Myeloid-derived Suppressor Cells in Metastatic Melanoma Patients Receiving Anti-CTLA4 Antibody and Interferon-α or TLR-9 Agonist and GM-CSF With Peptide Vaccination

(2012) Ahmad A. Tarhini et al.   JOURNAL OF IMMUNOTHERAPY

Sequential Immunotherapy by Vaccination With GM-CSF–expressing Glioma Cells and CTLA-4 Blockade Effectively Treats Established Murine Intracranial Tumors

(2012) Pankaj Agarwalla et al.   JOURNAL OF IMMUNOTHERAPY

Increase of regulatory T cells in metastatic stage and CTLA-4 over expression in lymphocytes of patients with non-small cell lung cancer (NSCLC)

(2012) Nasrollah Erfani et al.   LUNG CANCER

Monitoring of Regulatory T Cell Frequencies and Expression of CTLA-4 on T Cells, before and after DC Vaccination, Can Predict Survival in GBM Patients

(2012) Brendan Fong et al.   PLoS One

A Multi-Factorial Genetic Model for Prognostic Assessment of High Risk Melanoma Patients Receiving Adjuvant Interferon

(2012) Ena Wang et al.   PLoS One

Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model

(2012) P. Yu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Genetic Variation in Donor CTLA-4 Regulatory Region is a Strong Predictor of Outcome after Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies

(2011) Madan Jagasia et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Cancer immunotherapy comes of age

(2011) Ira Mellman et al.   NATURE

CTLA-4 +49A>G Polymorphism Is Associated with Advanced Non-Small Cell Lung Cancer Prognosis

(2011) Bao Song et al.   RESPIRATION

Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4

(2011) O. S. Qureshi et al.   SCIENCE

New Insights of CTLA-4 into Its Biological Function in Breast Cancer

(2010) H. Mao et al.   CURRENT CANCER DRUG TARGETS

CTLA-4 is expressed by human monocyte—derived dendritic cells and regulates their functions

(2010) Stefania Laurent et al.   HUMAN IMMUNOLOGY

Circulating soluble CTLA-4 is related to inflammatory markers in the 70 year old population

(2010) Priya Sakthivel et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

CTLA4 gene variations and haplotypes in patients with lung cancer

(2009) Narges Khaghanzadeh et al.   CANCER GENETICS AND CYTOGENETICS

Polymorphisms in the CD28/CTLA4/ICOS genes: role in malignant melanoma susceptibility and prognosis?

(2009) Marna G. Bouwhuis et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Influence of CTLA-4/CD28/ICOS gene polymorphisms on the susceptibility to cervical squamous cell carcinoma and stage of differentiation in the Polish population

(2009) Edyta Pawlak et al.   HUMAN IMMUNOLOGY

A functional soluble form of CTLA-4 is present in the serum of celiac patients and correlates with mucosal injury

(2009) R. Simone et al.   INTERNATIONAL IMMUNOLOGY

CTLA-4 +49A>G polymorphism is associated with the risk but not with the progression of colorectal cancer in Chinese

(2009) Peng Qi et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Investigation ofCTLA-4andCD28gene polymorphisms in a group of Turkish patients with colorectal cancer

(2008) F. Dilmec et al.   International Journal of Immunogenetics

CTLA-4 genotype and relapse incidence in patients with acute myeloid leukemia in first complete remission after induction chemotherapy

(2008) A Pérez-García et al.   LEUKEMIA

MDR1 Single Nucleotide Polymorphism G2677T/A and Haplotype Are Correlated with Response to Docetaxel-Cisplatin Chemotherapy in Patients with Non-Small-Cell Lung Cancer

(2008) Ji-hong Pan et al.   RESPIRATION